Sartorius Stedim Biotech S.A. (SDMHF) Financials
SDMHF Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
March 31, 2025 | 9.0 billion | 4.6 billion |
Dec. 31, 2024 | 8.6 billion | 4.4 billion |
Sept. 30, 2024 | 8.9 billion | 4.5 billion |
June 30, 2024 | 8.7 billion | 4.4 billion |
SDMHF Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
March 31, 2025 | 59.0 million | ? |
Dec. 31, 2024 | 213.4 million | ? |
Sept. 30, 2024 | 209.5 million | ? |
June 30, 2024 | 146.1 million | ? |
SDMHF Net Income
Date | Net Income |
---|---|
March 31, 2025 | 124.8 million |
Dec. 31, 2024 | 42.6 million |
Sept. 30, 2024 | 39.5 million |
June 30, 2024 | 51.1 million |
SDMHF Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
March 31, 2025 | 786.5 million | 3.1 billion | 194.9 million |
Dec. 31, 2024 | 717.3 million | 2.9 billion | 151.6 million |
Sept. 30, 2024 | 557.7 million | 3.1 billion | 155.2 million |
June 30, 2024 | 487.5 million | 3.0 billion | 113.0 million |
SDMHF Shares Outstanding
SDMHF Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
March 31, 2025 | 70.6 million | 42.4 million | 180.1 million | 137.2 million |
Dec. 31, 2024 | 83.3 million | 38.6 million | 181.2 million | 126.6 million |
Sept. 30, 2024 | 78.4 million | 41.5 million | 173.4 million | 131.9 million |
June 30, 2024 | 86.1 million | 37.8 million | 169.9 million | 127.6 million |
SDMHF Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
March 31, 2025 | 805.5 million | 420.1 million |
Dec. 31, 2024 | 782.4 million | 453.0 million |
Sept. 30, 2024 | 729.9 million | 423.2 million |
June 30, 2024 | 758.3 million | 429.5 million |
SDMHF
Price: $221
Dividend Yield: 0.35%
Forward Dividend Yield: 0.34%
Payout Ratio: 37.53%
Dividend Per Share: 0.74 USD
Earnings Per Share: 2.38 USD
P/E Ratio: 100.19
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 23.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 16
DGR3: 13.18%
DGR5: 25.36%
DGR10: 12.13%